Berges, R., Höfner, K., Muschter, R.: Alternative / minimal-invasive Therapien bei benignem Prostatasyndrom (BPS). Deutsches Ärzteblatt 2006, in Press
Berges, R., Bello, U.: Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancer. CMRO, accepted for publication 02/2006.
Chapple, C., Artibani, W., Berges, R., Kaplan, S. Michel, M.C., Perrin, P., Prezidioso, D. Takeda, M. Tammela, T.L. Teillac, P.: Committee 6, New Medical Developments in the Management of LUTS in Adult Men. 6th International Consultations on prostate cancer and prostatic dieseases. Paris 2006 in Press
van Exel, N. J., Koopmanschap, M. A., McDonnell, J., Chapple, C. R., Berges, R., Rutten, F. F.: Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study. Eur Urol, 49: 92, 2006
Zlotta, A., Abrahamsson, P., Tombal,B., Berges, R., Debruyne, F.:Hormone therapy: improving therapy decisions and monitoring. Eur Urol (Suppl.) 2006 in Press
Chapple, C., Batista, J., Berges, R., Chartier-Kastler, E.,Tubaro, A., Van Kerrebroeck , V., Herman Stoevelaar, H.: The Impact of Nocturia in Patients with LUTS/BPH: Need for New Recommendations. Eur Urol (Suppl.) 5,12-18, 2006